NET ASSET VALUE 2024 06 30

MARKN.

On the 30 June 2024 Flerie AB's ("Flerie") Net Asset Value (NAV) was SEK 4,380 million and NAV per share was SEK 0.561.

Allocation of net asset valueShare of portfolio companyFair value (MSEK)Part of NAV per share (SEK)Share of NAV
     
Product Development    
Prokarium42%4710.06010.8%
Xspray Pharma17%4610.05910.5%
Empros Pharma79%2040.0264.7%
KAHR Medical31%2000.0264.6%
Atrogi34%1540.0203.5%
Microbiotica11%1340.0173.1%
Xintela56%1050.0132.4%
Mendus24%1030.0132.4%
Geneos Therapeutics12%1020.0132.3%
Lipum57%980.0132.2%
Toleranzia58%760.0101.7%
Synerkine Pharma43%520.0071.2%
AnaCardio19%520.0071.2%
Egetis Therapeutics2%340.0040.8%
Buzzard Pharmaceuticals14%290.0040.7%
Vitara Biomedical5%280.0040.6%
Sixera Pharma23%260.0030.6%
Alder Therapeutics21%170.0020.4%
Amarna Therapeutics60%120.0010.3%
Strike Pharma14%60.0010.1%
EpiEndo Pharmaceuticals10%00.0000.0%
Total 2,3650.30354.0%
    
Commercial Growth   
NorthX Biologics92%1890.0244.3%
Symcel31%1690.0223.9%
Nanologica39%950.0122.2%
A3P Biomedical8%750.0101.7%
Provell Pharmaceuticals72%670.0091.5%
Chromafora32%530.0071.2%
Frontier Biosolutions2%190.0020.4%
Bohus Biotech45%170.0020.4%
Total 6830.08815.6%
    
Limited Partnerships, total 760.0101.7%
    
Assets related to portfolio companies 3760.0488.6%
Other assets and liabilities 8790.11320.1%
    
Net asset value 4,3800.561100.0%
  

 
* indirect shares in Provell Pharmaceuticals    
Datum 2024-07-05, kl 08:00
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!